Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 3/2020

Inhalt (17 Artikel)

Open Access Review

The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

Akshay J. Patel, Alex Richter, Mark T. Drayson, Gary W. Middleton

Open Access Original Article

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer

Simer J. Bains, Hanna Abrahamsson, Kjersti Flatmark, Svein Dueland, Knut H. Hole, Therese Seierstad, Kathrine Røe Redalen, Sebastian Meltzer, Anne Hansen Ree

Original Article

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients

Junxun Ma, Danyang Sun, Jinliang Wang, Chun Han, Yuanyu Qian, Guangying Chen, Xiaoyan Li, Juan Zhang, Pengfei Cui, Wushuang Du, Zhaozhen Wu, Shixue Chen, Xuan Zheng, Zhichao Yue, Jia Song, Chan Gao, Shangli Cai, Yi Hu

Original Article

Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients

Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R. Madiyalakan, Yolanda D. Mahnke, Christopher Nicodemus

Original Article

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study

Guowei Zhang, Ruirui Cheng, Huijuan Wang, Yong Zhang, Xiangtao Yan, Peng Li, Mina Zhang, Xiaojuan Zhang, Jinpo Yang, Yuanyuan Niu, Zhiyong Ma

Original Article

Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas

Mikael Roussel, Faustine Lhomme, Caroline E. Roe, Todd Bartkowiak, Pauline Gravelle, Camille Laurent, Thierry Fest, Jonathan M. Irish

Original Article

The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide

Subhashis Sarkar, Sachin K. S. Chauhan, John Daly, Alessandro Natoni, Heather Fairfield, Robert Henderson, Emma Nolan, Dawn Swan, Jinsong Hu, Michaela R. Reagan, Michael O’Dwyer

Open Access Original Article

Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer

Caroline Bergenfelz, Anna Roxå, Meliha Mehmeti, Karin Leandersson, Anna-Maria Larsson

Open Access Original Article

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy

Remy Thomas, Hibah Shaath, Adviti Naik, Salman M. Toor, Eyad Elkord, Julie Decock

Original Article

The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

Hongzhi Quan, Zhongyan Shan, Ziyi Liu, Sixuan Liu, Liu Yang, Xiaodan Fang, Kun Li, Baisheng Wang, Zhiyuan Deng, Yanjia Hu, Zhigang Yao, Junhui Huang, Jianjun Yu, Kun Xia, Zhangui Tang, Liangjuan Fang

Open Access Clinical Trial Report

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

Steve Boudewijns, Martine Bloemendal, Nienke de Haas, Harm Westdorp, Kalijn F. Bol, Gerty Schreibelt, Erik H. J. G. Aarntzen, W. Joost Lesterhuis, Mark A. J. Gorris, Alexandra Croockewit, Lieke L. van der Woude, Michelle M. van Rossum, Marieke Welzen, Anna de Goede, Stanleyson V. Hato, Winette T. A. van der Graaf, Cornelis J. A. Punt, Rutger H. T. Koornstra, Winald R. Gerritsen, Carl G. Figdor, I. Jolanda M. de Vries

Letter to the Editors

PCSK9 is a promising prognostic marker in patients with advanced NSCLC

Aldo Bonaventura, Francesco Grossi, Fabrizio Montecucco

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.